Literature DB >> 11598066

Interaction of Neisseria meningitidis with human dendritic cells.

A Kolb-Mäurer1, A Unkmeir, U Kämmerer, C Hübner, T Leimbach, A Stade, E Kämpgen, M Frosch, G Dietrich.   

Abstract

Infection with Neisseria meningitidis serogroup B is responsible for fatal septicemia and meningococcal meningitis. The severity of disease directly correlates with the production of the proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), IL-6, and IL-8. However, the source of these cytokines has not been clearly defined yet. Since bacterial infection involves the activation of dendritic cells (DCs), we analyzed the interaction of N. meningitidis with monocyte-derived DCs. Using N. meningitidis serogroup B wild-type and unencapsulated bacteria, we found that capsule expression significantly impaired neisserial adherence to DCs. In addition, phagocytic killing of the bacteria in the phagosome is reduced by at least 10- to 100-fold. However, all strains induced strong secretion of proinflammatory cytokines TNF-alpha, IL-6, and IL-8 by DCs (at least 1,000-fold at 20 h postinfection [p.i.]), with significantly increased cytokine levels being measurable by as early as 6 h p.i. Levels of IL-1beta, in contrast, were increased only 200- to 400-fold at 20 h p.i. with barely measurable induction at 6 h p.i. Moreover, comparable amounts of cytokines were induced by bacterium-free supernatants of Neisseria cultures containing neisserial lipooligosaccharide as the main factor. Our data suggest that activated DCs may be a significant source of high levels of proinflammatory cytokines in neisserial infection and thereby may contribute to the pathology of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598066      PMCID: PMC100071          DOI: 10.1128/IAI.69.11.6912-6922.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  Meningococcal vaccines.

Authors:  D M Jones
Journal:  J Med Microbiol       Date:  1993-02       Impact factor: 2.472

2.  Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis.

Authors:  S Hammerschmidt; C Birkholz; U Zähringer; B D Robertson; J van Putten; O Ebeling; M Frosch
Journal:  Mol Microbiol       Date:  1994-03       Impact factor: 3.501

3.  Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis.

Authors:  S Ohga; T Aoki; K Okada; H Akeda; K Fujioka; A Ohshima; T Mori; I Minamishima; K Ueda
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 4.  Bacterial meningitis: mechanisms of disease and therapy.

Authors:  R F Kornelisse; R de Groot; H J Neijens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

5.  Interactions of Neisseria meningitidis with human monocytes.

Authors:  G McNeil; M Virji; E R Moxon
Journal:  Microb Pathog       Date:  1994-02       Impact factor: 3.738

6.  Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines.

Authors:  D R Lorenzen; F Düx; U Wölk; A Tsirpouchtsidis; G Haas; T F Meyer
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

7.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.

Authors:  K Inaba; M Inaba; M Naito; R M Steinman
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

8.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

9.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation.

Authors:  D J Cassell; R H Schwartz
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  11 in total

1.  Transcriptome analysis of Neisseria meningitidis during infection.

Authors:  Guido Dietrich; Sebastian Kurz; Claudia Hübner; Christian Aepinus; Stephanie Theiss; Matthias Guckenberger; Ursula Panzner; Jacqueline Weber; Matthias Frosch
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

Review 2.  Meningococcal glycoconjugate vaccines.

Authors:  Roberto Gasparini; Donatella Panatto
Journal:  Hum Vaccin       Date:  2011-02-01

3.  Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells.

Authors:  Alexandra Unkmeir; Ulrike Kämmerer; Anne Stade; Claudia Hübner; Sabine Haller; Annette Kolb-Mäurer; Matthias Frosch; Guido Dietrich
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasin.

Authors:  Virginie Nägele; Jürgen Heesemann; Stephanie Schielke; Luisa F Jiménez-Soto; Oliver Kurzai; Nikolaus Ackermann
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

5.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

6.  Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains.

Authors:  Reidun Ovstebø; Ole Kristoffer Olstad; Berit Brusletto; Anne Sophie Møller; Audun Aase; Kari Bente Foss Haug; Petter Brandtzaeg; Peter Kierulf
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

7.  Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains.

Authors:  Alison C Pridmore; Gary A Jarvis; Constance M John; Dominic L Jack; Steven K Dower; Robert C Read
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 8.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

9.  Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model.

Authors:  Damian Clarke; Corinne Letendre; Marie-Pier Lecours; Paul Lemire; Tristan Galbas; Jacques Thibodeau; Mariela Segura
Journal:  J Immunol Res       Date:  2016-02-16       Impact factor: 4.818

10.  Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.

Authors:  Naseem Mushtaq; Maria B Redpath; J Paul Luzio; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.